Matthew Todd
Professor of Drug Discovery at University College London
Meet Matthew Todd
Todd founded and currently leads various open-source drug discovery consortia, including Open Source Malaria, Open Source Antibiotics, and MycetOS. These focus on ways that open science can accelerate the discovery of new medicines: all data and ideas are freely shared, anyone may participate, and there are no patents. His research interests span drug discovery and the development of new synthetic methods.
“Small molecules can be tremendously powerful, effective, safe, inexpensive, and (because of their simplicity) ‘democratisable’ in that lots of laboratories can be involved in their optimization. We need every weapon available if we are to combat disease more effectively.”